tirzepatide head to head semaglutide vs. for Weight Loss First head-to-head trial compares tirzepatide

El programa de estudios SURMOUNT ha proporcionado datos particularmente convincentes sobre los efectos del medicamento en personas con obesidad o sobrepeso

Convenient Daily Capsule Easy-to-take capsule format fits seamlessly into any supplement regimen, with 100 servings per container for long-lasting use

If you experience these symptoms, seek medical attention right away

Brand-Name Costs (Without Insurance): Oral Semaglutide (Rybelsus): List Price: $900-$1,000 per month 30-day supply (30 tablets) Must take daily Annual cost: $10,800-$12,000 Injectable Semaglutide (Wegovy): List Price: $1,349 per month 4-5 weekly injections per pack Weekly dosing Annual cost: $16,188 Injectable Tirzepatide (Zepbound): List Price: $1,069 per month 4 weekly injections per pack Weekly dosing Annual cost: $12,828 With Insurance Coverage: Oral Semaglutide: More likely to be covered for diabetes Weight loss coverage varies Copay: $25-$300/month with insurance Prior authorization usually required Injectable Semaglutide (Wegovy): Covered by some insurance for weight loss Copay: $25-$300/month with insurance Extensive prior authorization requirements May require failed weight loss attempts first Injectable Tirzepatide (Zepbound): Newer to market, less insurance coverage for weight loss Copay: $25-$300/month with insurance Even more restrictive prior authorization Many plans dont cover yet for weight loss Compounded Injectable Options: Compounded Semaglutide: TrimRx price: $199/month with annual commitment Other providers: $199-$599/month No insurance coverage but HSA/FSA eligible Annual cost: $2,388-$7,188 Compounded Tirzepatide: TrimRx price: $349/month with annual commitment Other providers: $349-$699/month No insurance coverage but HSA/FSA eligible Annual cost: $4,188-$8,388 No Compounded Oral Options: Compounding pharmacies cannot create oral semaglutide because the SNAC absorption technology is proprietary and patented

Nutrients 2018, Vol